G) Microarray analysis was performed to compare the gene expression patterns of rat iPSCs, other pluripotent cells (mouse ESCs and human ESCs), and nonpluripotent populations from each species. The hierarchical cluster analysis of 12355 orthologous genes in rat, mouse, and human was performed based on the signal ratio. The distances between the samples are shown. Full details of the microarray analysis are available in the Supplemental Data.
The laboratory rat (Rattus norvegicus) was the first mammalian species domesticated for scientific research, and it has been used as an animal model for physiology, pharmacology, toxicology, nutrition, behavior, immunology, and neoplasia for over 150 years (Jacob, 1999) . Despite this history, the rat lags far behind the mouse in functional genetic studies and generation of human disease models because of the absence of functional germline-competent rat embryonic stem cells (ESCs), which are vital in reverse genetics approach. Here, we report the generation of induced pluripotent stem cells (iPSCs) from adult rat cells and demonstrate that the iPSC technique provides a feasible approach to establish pluripotent stem cells for a species in which ESCs have previously proven to be difficult to establish from the early embryo.
After the first mouse ESC lines were derived 27 years ago (Evans and Kaufman, 1981; Martin, 1981) , many efforts were made to establish rat ESCs, without success to date (Brenin et al., 1997; Demers et al., 2007; Iannaccone et al., 1994; Mashimo et al., 2008; Schulze et al., 2006; Ueda et al., 2008; Vassilieva et al., 2000) . All of the reported cell lines could only be termed ESC-like cells because they did not meet the criteria of ESCs in one or more of the following aspects: (1) few cell lines could proliferate for a long period of time while remaining undifferentiated and maintaining normal karyotypes; (2) an advanced teratoma containing all three germ layers was not reported when the cells were injected into immune-deficient mice, suggesting that these rat ESC-like cells lacked the ability to differentiate into derivatives of all three germ layers; and (3) when rat ESC-like cells were injected into a blastocyst, the cells only contributed to extraembryonic tissue. No convincing evidence was reported that the cells could contribute to other tissues (Brenin et al., 1997; Demers et al., 2007; Ueda et al., 2008) . These unsuccessful attempts suggest that establishing rat ESCs from a blastocyst might not be feasible using traditional methods.
Another type of pluripotent stem cells called induced pluripotent stem cells (iPSCs) can be generated by reprogramming adult cells using defined transcription factors (Liao et al., 2008; Park et al., 2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007) . Although the first reported mouse iPSCs did not show germline transmission (Takahashi and Yamanaka, 2006) , germline transmission and homologous recombination were recently demonstrated (Hanna et al., 2007; Okita et al., 2007; Wernig et al., 2007) . These reports suggest that iPSCs can replace ESCs in vivo to generate gene knockout and knockin strains. Thus, iPSCs could be extremely valuable, especially for rat and other species in which ESCs are not available, or difficult to isolate.
The rat primary ear fibroblast (PEF) or primary bone marrow (BMC) cells used in this report were derived from 10week-old SD rats. A schematic diagram of the reprogramming protocol is shown in Figure 1A , and detailed Experimental Procedures are included in the Supplemental Data online. Virus containing a cocktail of reprogramming factors was used to transduce the adult cells. Two days after transduction, the cells were harvested by trypsinization and plated onto MEF (murine embryonic fibroblast cells) at 5 3 10 4 cells per well of a sixwell plate. The next day, the medium (DMEM containing 10% FBS) was re-placed with medium for ESC culture (knockout DMEM + 10% FBS + 10% serum replacement without LIF).
First, we tried to use retrovirus containing SY4 genes (Oct4, Sox2, Klf4, and c-Myc) to reprogram both adult rat cells and murine fibroblast cells (as a positive control). This retroviral transduction yielded ESC-like colonies from the mouse cells, and these colonies could be successfully expanded (data not shown). We could also easily transduce the rat cells with a control retrovirus expressing EGFP (data not shown), indicating that the rat cells express the retrovirus receptor. Although the retroviral transduction could generate a few ESC-like colonies from the rat cells, these colonies could not be expanded (data not shown). These observations suggested that the retroviral system was not sufficient to generate ESC-like rat cells from adult rat cells.
We then tried to reprogram the adult rat cells with lentivirus containing a cocktail of reprogramming factors. We compared side by side the efficiency of iPSC production by transduction with lentiviral vectors expressing either SY4 (Oct4, Sox2, c-Myc, and Klf4 [OSMK]) or JT4 (Oct4, Sox2, Nanog, and Lin28 [OSNL]) genes. We found that the JT4 cocktail could not generate any alkaline phosphatase (AP)-positive colonies, whereas transduction with the SY4 gene combination gave rise to a significant number of AP-positive colonies ( Figure 1B) .
Colonies with an ESC-like morphology generated by SY4 genes first became visible 7 days after transduction. On day 10, the ESC-like colonies were large and round with clear boundaries (Figure 1Ca ). On day 10, we picked ESC-like colonies from 50% of the wells, trypsinized them into single cells, and transferred them to (E) Quantitative reverse transcription-PCR analyses of total (black bars) and endogenous (white bars) Oct4, Sox2, cMyc, and Nanog expression in rat iPSCs versus parental populations. y axis is defined as the copy number of target gene per 10 6 copies of GAPDH.
(F) Quantitative reverse transcription-PCR analyses of endogenous Oct4 and Nanog expression in mESC and rat iPSCs relative to parental somatic cell populations. y axis is defined as the copy number of target gene per 10 6 copies of GAPDH.
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Brief Report 96-well plates for further expansion. The remaining wells were subjected to AP staining. The number of AP-positive colonies is shown in Figure 1B . We observed about 27 and 12 ESC-like colonies reprogrammed by lentiviruses containing SY4 genes from 5 3 10 4 PEF or BMC, respectively. The rat ESC-like cells (named rat iPSCs) could be expanded on MEF feeder cells with ESC medium. They formed tightly packed colonies similar to mouse ESCs (Figures 1Cc and 1Cd ). Each cell exhibited morphology similar to that of mouse ESCs, characterized by a high ratio of nucleus to cytoplasm and prominent nucleoli (Figure 1Cd ). The doubling time of rat iPSC line M13 is 11.30 ± 0.67 hr. Plating efficiency is 21.82% ± 1.82%. The doubling time of rat iPSC line F65 is 10.07 ± 1.05 hr. Plating efficiency is 26.83% ± 1.99%. Rat iPSC line M13 has now been passaged continuously for more than 36 passages (more than 3 months). Rat iPSC line F65 has now been passaged continuously for more than 38 passages (more than 3 months). Rat iPSCs grew well in the media without LIF. Under feeder-free conditions, LIF could not inhibit the differentiation or maintain the expression of endogenous Oct4 and Nanog ( Figure S1 ). Therefore, it might not be appropriate to use LIF as the key growth factor to derive rat ESCs from blastocysts, which might partially explain the unsuccessful establishment of rat ESCs to date. Like mouse ESCs, rat iPSCs expressed AP, stage-specific embryonic antigen (SSEA)-1, and Nanog protein ( Figure 1C ). They did not express hESC-specific surface antigens SSEA-3 or SSEA-4 (data not shown). RT-PCR showed that rat iPSCs expressed many undifferentiated ESC-marker genes, including Oct3/4, Sox2, Nanog, Nodal, fibroblast growth factor 4 (FGF4), Gabrb, Gal, Leftyb, and Lin28 ( Figure 1D) .
We analyzed the expression of endogenous Oct4, Nanog, and Sox2 and found that all three were robustly induced, although some of the exogenous genes were not fully silenced, likely due to the properties of the lentivirus ( Figure 1E ). We used absolute quantitative PCR to calculate the mRNA copy number of Oct4 and Nanog in both rat iPSCs and mESCs and found that the expression of endogenous Oct4 and Nanog in rat iPSCs was comparable to that in mESCs ( Figure 1F ). These observations suggest that endogenous pluripotency genes (e.g., oct4 and nanog) can be fully induced by reprogramming.
To gain a global view of the reprogramming, microarray analysis was performed to compare the patterns of gene expression exhibited by rat iPSCs, other pluripotent cells (mouse ESCs and human ESCs), and nonpluripotent cells. We found the gene expression profiles of rat iPSC line F65 and M13 were significantly different from the adult cells (Tables S4-S6 ). However, they are very similar to each other, despite having been reprogrammed from different populations of adult cells ( Figure 1G and Tables S4-S6). These observations suggested that rat iPSC lines F65 and M13 were reprogrammed to a similar state. A hierarchical cluster analysis of 12,355 orthologous genes in rat, mouse, and human was performed based on the gene expression profiles. The results showed that the pluripotent cells, although derived from different species, cluster together, whereas the nonpluripotent cells cluster separately. This analysis also revealed that the rat iPSCs cluster more closely with mouse and human ESCs than to the nonpluripotent populations. These data suggested that the rat iPSCs were reprogrammed faithfully to pluripotent state similar to that of mouse and human ESCs. The detailed gene expression profiles are provided in the Supplemental Data.
Bisulfite genomic sequencing analyses of the Oct4 promoter showed that it is highly unmethylated in rat iPSC clones, whereas CpG dinucleotides in these regions were highly methylated in parental PEFs and BMCs (Figure 2A) . These results indicate that the Oct4 promoter is active in rat iPSCs. Rat iPSCs also showed high levels of telomerase activity ( Figure 2B) . We also performed karyotyping after passage 15, and our analyses suggested that the rat iPSC clones showed a normal karyotype of 42XY ( Figure 2C) .
In order to determine the differentiation capacity of rat iPSCs in vitro, we allowed the rat iPSCs to differentiate for 7 days and analyzed the presence of differentiation markers.
RT-PCR confirmed that the rat iPSCs could differentiate into all three germ layers in embryoid bodies, as evidenced by the expression of SRY box containing gene 17 (Sox17, endoderm), AFP (endoderm), MyoD (mesoderm), SM22-a (mesoderm), NCAM (ectoderm), and paired box 6 (Pax6, ectoderm) ( Figure 2D ). In contrast, endogenous Oct3/4, Sox2, and Nanog expression was markedly decreased (Figure 2D) . These data demonstrate that iPSCs can differentiate into three germ layers in vitro.
To test pluripotency in vivo, rat iPSCs were injected intramuscularly into nonobese diabetic/severe combined immunedeficient (NOD/SCID) mice. Four weeks after injection, we observed tumor formation. Histological examination showed that the tumor contained various tissues, including gut-like epithelial tissues (endoderm), bone (mesoderm), cartilage (mesoderm), and neural tissues (ectoderm) ( Figure 2E ). The characterizations of rat iPSCs were summarized in Table S1 .
The results presented here have a number of important implications. First and most importantly, we demonstrated proof of principle that the iPSC technique provides a feasible approach to establish pluripotent stem cells for a species in which ESCs have proven to be difficult to establish from the early embryo. Pluripotent stem cell lines that can proliferate for long periods of time without differentiation are vital for targeted gene modification in vivo (Capecchi, 1989) . ESC lines of many species such as pig, cow, goat, and sheep are highly desirable, and many efforts have been invested without success over the past two decades (Keefer et al., 2007) . We propose that the iPSC technology could be used to generate pluripotent stem cell lines for species in which ESC lines are desirable but cannot be established from the early embryo.
Second, the study of the mechanisms that maintain stemness based on rat iPSCs might provide clues for establishing rat ESCs. Although rat and mouse are both rodents and are similar in many aspects, it is intriguing that rat ESCs have yet to be established from the early embryo, despite many attempts. Compared with the previously reported rat ESC-like cells, the rat iPSCs reported here exhibit several desirable traits. First, the rat iPSCs are able to proliferate for a long period of time, and yet they maintain a normal karyotype. Second, the rat iPSCs can form teratoma-containing tissue from all three germ layers in vivo.
There could be many reasons that rat ESC lines have not yet been established. It could be that the necessary culture conditions required to maintain the stemness of rat ESCs have not been achieved. The generation of rat iPSCs, which have similar properties to ESCs, might allow us to study the mechanisms that are essential to maintain the stemness of rat ESCs. We found that LIF could not maintain the expression of endogenous Oct4 and Nanog in rat iPSCs under feeder-free conditions. Based on the same principle, we can further characterize the signaling pathways that regulate the expression of endogenous Oct4 and Nanog in rat iPSCs. The data acquired from these studies might give insight into achieving the proper culture conditions to derive rat ESCs from the early embryo.
Finally, the rat iPSCs are able to proliferate for a long period of time without differentiation. These properties provide an opportunity for using the homologous recombination technique in rat iPSCs. The successful demonstration of germline transmission and homologous recombination in mouse iPSCs encourages us to propose that rat iPSCs might be directly used to generate knockout and knockin rats once germline transmission is demonstrated. This could make the rat a premier model for human diseases. Due to the unavailability of an efficient rat embryonic manipulation system, we have so far not been able to demonstrate the generation of chimera from our rat iPSCs. However, we demonstrated that the rat iPSCs could proliferate rapidly for long-term and maintain pluripotency. These observations suggest that rat iPSCs should be able to contribute to chimera if an efficient rat embryonic manipulation system is available. The remaining challenge is to establish a protocol to generate chimeric rats with germline transmission by using rat iPSCs. Viral integration into the genome might be temporarily resolved by backcrossing to wild-type rats six times, or it might be ultimately resolved by generating rat iPSCs without vector integration into the genome. 
